Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1974 Dec;30(6):538–548. doi: 10.1038/bjc.1974.233

Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review.

J C Underwood
PMCID: PMC2009334  PMID: 4614858

Full text

PDF
538

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archibald R. B., Frenster J. H. Quantitative ultrastructural analysis of in vivo lymphocyte-Reed-Sternberg cell interactions in Hodgkin's disease. Natl Cancer Inst Monogr. 1973 May;36:239–245. [PubMed] [Google Scholar]
  2. BERG J. W. Inflammation and prognosis in breast cancer; a search for host resistance. Cancer. 1959 Jul-Aug;12(4):714–720. doi: 10.1002/1097-0142(195907/08)12:4<714::aid-cncr2820120414>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  3. BLACK M. M., OPLER S. R., SPEER F. D. Microscopic structure of gastric carcinomas and their regional lymph nodes in relation to survival. Surg Gynecol Obstet. 1954 Jun;98(6):725–734. [PubMed] [Google Scholar]
  4. BLACK M. M., OPLER S. R., SPEER F. D. Survival in breast cancer cases in relation to the structure of the primary tumor and regional lymph nodes. Surg Gynecol Obstet. 1955 May;100(5):543–551. [PubMed] [Google Scholar]
  5. Bennett S. H., Futrell J. W., Roth J. A., Hoye R. C., Ketcham A. S. Prognostic significance of histologic host response in cancer of the larynx or hypopharynx. Cancer. 1971 Nov;28(5):1255–1265. doi: 10.1002/1097-0142(1971)28:5<1255::aid-cncr2820280524>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  6. Berg J. W. Morphological evidence for immune response to breast cancer. An historical review. Cancer. 1971 Dec;28(6):1453–1456. doi: 10.1002/1097-0142(197112)28:6<1453::aid-cncr2820280618>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  7. Birbeck M. S., Carter R. L. Observations on the ultrastructure of two hamster lymphomas with particular reference to infiltrating macrophages. Int J Cancer. 1972 Mar 15;9(2):249–257. doi: 10.1002/ijc.2910090202. [DOI] [PubMed] [Google Scholar]
  8. Black M. M., Leis H. P., Jr Cellular responses to autologous breast cancer tissue. Correlation with stage and lymphoreticuloendothelial reactive. Cancer. 1971 Aug;28(2):263–273. doi: 10.1002/1097-0142(197108)28:2<263::aid-cncr2820280202>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  9. Blomgren H., Glas U., Franzén S., Granberg P. O. Lymphoid cells in carcinoma of the breast. Failure of response to phytohaemagglutinin in vitro. Acta Radiol Ther Phys Biol. 1973 Oct;12(5):434–442. doi: 10.3109/02841867309130410. [DOI] [PubMed] [Google Scholar]
  10. Bloom H. J., Richardson W. W., Field J. R. Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. Br Med J. 1970 Jul 25;3(5716):181–188. doi: 10.1136/bmj.3.5716.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Burg G., Braun-Falco O. The cellular stromal reaction in malignant melanoma. A cytochemical investigation. Arch Dermatol Forsch. 1972;245(4):318–333. doi: 10.1007/BF00595637. [DOI] [PubMed] [Google Scholar]
  12. Carr I., Underwood J. C. The ultrastructure of the local cellular reaction to neoplasia. Int Rev Cytol. 1974;37(0):329–347. doi: 10.1016/s0074-7696(08)61361-3. [DOI] [PubMed] [Google Scholar]
  13. Chambers V. C., Weiser R. S. The ultrastructure of sarcoma I cells and immune macrophages during their interaction in the peritoneal cavities of immune C57BL-6 mice. Cancer Res. 1972 Feb;32(2):413–419. [PubMed] [Google Scholar]
  14. Champion H. R., Wallace I. W., Prescott R. J. Histology in breast cancer prognosis. Br J Cancer. 1972 Apr;26(2):129–138. doi: 10.1038/bjc.1972.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cochran A. J. Histology and prognosis in malignant melanoma. J Pathol. 1969 Mar;97(3):459–468. doi: 10.1002/path.1710970305. [DOI] [PubMed] [Google Scholar]
  16. Currie G. A., Lejeune F., Fairley G. H. Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma. Br Med J. 1971 May 8;2(5757):305–310. doi: 10.1136/bmj.2.5757.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Cutler S. J., Black M. M., Mork T., Harvei S., Freeman C. Further observations on prognostic factors in cancer of the female breast. Cancer. 1969 Oct;24(4):653–667. doi: 10.1002/1097-0142(196910)24:4<653::aid-cncr2820240402>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  18. DREYER D. A., SHULLENBERGER C. C., DMOCHOWSKI L. A STUDY ON INTRACELLULAR LYMPHOCYTES ("EMPERIPOLESIS") IN TISSUE CULTURE OF LYMPH NODES FROM PATIENTS WITH MALIGNANT LYMPHOMA. Tex Rep Biol Med. 1964;22:61–69. [PubMed] [Google Scholar]
  19. Dvorak H. F., Dvorak A. M., Churchill W. H. Immunologic rejection of diethylnitrosamine-induced hepatomas in strain 2 guinea pigs: participation of basophilic leukocytes and macrophage aggregates. J Exp Med. 1973 Mar 1;137(3):751–775. doi: 10.1084/jem.137.3.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Edwards A. J., Rowland G. F., Lee M. R. Reduction of lymphocyte transformation by a factor produced by gastrointestinal cancer. Lancet. 1973 Mar 31;1(7805):687–689. doi: 10.1016/s0140-6736(73)91477-3. [DOI] [PubMed] [Google Scholar]
  21. Elston C. W., Bagshawe K. D. Cellular reaction in trophoblastic tumours. Br J Cancer. 1973 Sep;28(3):245–256. doi: 10.1038/bjc.1973.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Evans R., Alexander P. Mechanism of immunologically specific killing of tumour cells by macrophages. Nature. 1972 Mar 24;236(5343):168–170. doi: 10.1038/236168a0. [DOI] [PubMed] [Google Scholar]
  23. Evans R. Macrophages in syngeneic animal tumours. Transplantation. 1972 Oct;14(4):468–473. doi: 10.1097/00007890-197210000-00011. [DOI] [PubMed] [Google Scholar]
  24. Fisher E. R., Fisher B. Local lymphoid response as an index of tumor immunity. Arch Pathol. 1972 Aug;94(2):137–146. [PubMed] [Google Scholar]
  25. Franssila K. O., Kalima T. V., Voutlainen A. Histologic classification of Hodgkin's disease. Cancer. 1967 Oct;20(10):1594–1601. doi: 10.1002/1097-0142(196710)20:10<1594::aid-cncr2820201005>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  26. Friedmann I., Michaels L., Bird E. S. Crystalline strucutes in lymphocytes. J Pathol. 1971 Dec;105(4):289–290. doi: 10.1002/path.1711050409. [DOI] [PubMed] [Google Scholar]
  27. GRACE J. T., Jr, KONDO T. Investigations of host resistance in cancer patients. Ann Surg. 1958 Oct;148(4):633–641. doi: 10.1097/00000658-195810000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. GRESHAM G. A., ACKERLEY A. G. Giant cell granulomata in regional lymph nodes of carcinoma. J Clin Pathol. 1958 May;11(3):244–250. doi: 10.1136/jcp.11.3.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Goldenberg V. E., Goldenberg N. S., Sommers S. C. Comparative ultrastructure of atypical ductal hyperplasia, intraductal carcinoma, and infiltrating ductal carcinoma of the breast. Cancer. 1969 Dec;24(6):1152–1169. doi: 10.1002/1097-0142(196912)24:6<1152::aid-cncr2820240614>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  30. Gough J. Hodgkin's disease; a correlation of histopathology with survival. Int J Cancer. 1970 Mar 15;5(2):273–281. doi: 10.1002/ijc.2910050216. [DOI] [PubMed] [Google Scholar]
  31. Graham R. M., Graham J. B. Mast cells and cancer of the cervix. Surg Gynecol Obstet. 1966 Jul;123(1):3–9. [PubMed] [Google Scholar]
  32. HUGHES L. E., LYTTON B. ANTIGENIC PROPERTIES OF HUMAN TUMOURS: DELAYED CUTANEOUS HYPERSENSITIVITY REACTIONS. Br Med J. 1964 Jan 25;1(5377):209–212. doi: 10.1136/bmj.1.5377.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. HUMBLE J. G., JAYNE W. H., PULVERTAFT R. J. Biological interaction between lymphocytes and other cells. Br J Haematol. 1956 Jul;2(3):283–294. doi: 10.1111/j.1365-2141.1956.tb06700.x. [DOI] [PubMed] [Google Scholar]
  34. Hamlin I. M. Possible host resistance in carcinoma of the breast: a histological study. Br J Cancer. 1968 Sep;22(3):383–401. doi: 10.1038/bjc.1968.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Hawley P. R., Westerholm P., Morson B. C. Pathology and prognosis of carcinoma of the stomach. Br J Surg. 1970 Dec;57(12):877–883. doi: 10.1002/bjs.1800571202. [DOI] [PubMed] [Google Scholar]
  36. Hellström I., Hellström K. E., Pierce G. E., Yang J. P. Cellular and humoral immunity to different types of human neoplasms. Nature. 1968 Dec 28;220(5174):1352–1354. doi: 10.1038/2201352a0. [DOI] [PubMed] [Google Scholar]
  37. Inokuchi K., Inutsuka S., Furusawa M., Soejima K., Ikeda T. Stromal reaction around tumor and metastasis and prognosis after curative gastrectomy for carcinoma of the stomach. Cancer. 1967 Nov;20(11):1924–1929. doi: 10.1002/1097-0142(196711)20:11<1924::aid-cncr2820201120>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  38. Ioachim H. L. Emperipolesis of lymphoid cells in mixed cultures. Lab Invest. 1965 Oct;14(10):1784–1794. [PubMed] [Google Scholar]
  39. Jones W. M., Williams W. J., Roberts M. M., Davies K. Malignant melanoma of the skin: prognostic value of clinical features and the role of treatment in 111 cases. Br J Cancer. 1968 Sep;22(3):437–451. doi: 10.1038/bjc.1968.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Keller A. R., Kaplan H. S., Lukes R. J., Rappaport H. Correlation of histopathology with other prognostic indicators in Hodgkin's disease. Cancer. 1968 Sep;22(3):487–499. doi: 10.1002/1097-0142(196809)22:3<487::aid-cncr2820220302>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  41. Kiely E., Greally M., Greally J. On the significance of lymphoid cell infiltration in hypernephromas. Ir J Med Sci. 1972 Jul-Sep;141(7):108–111. doi: 10.1007/BF03004633. [DOI] [PubMed] [Google Scholar]
  42. Landberg T., Larsson L. E. Hodgkin's disease. Retrospective clinico-pathologic study in 149 patients. Acta Radiol Ther Phys Biol. 1969 Oct;8(5):390–414. doi: 10.3109/02841866909134467. [DOI] [PubMed] [Google Scholar]
  43. Lauder I., Aherne W. The significance of lymphocytic infiltration in neuroblastoma. Br J Cancer. 1972 Aug;26(4):321–330. doi: 10.1038/bjc.1972.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Lieb L. M., Lisco H. In vitro uptake of tritiated thymidine by carcinoma of the human colon. Cancer Res. 1966 Apr;26(4):733–740. [PubMed] [Google Scholar]
  45. Lopes Cardozo E., Harting M. C. On the function of lymphocytes in malignant effusions. Acta Cytol. 1972 Jul-Aug;16(4):307–313. [PubMed] [Google Scholar]
  46. Lukes R. J., Butler J. J. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1063–1083. [PubMed] [Google Scholar]
  47. MONAFO W. W., Jr, KRAUSE G. L., Jr, MEDINA J. G. Carcinoma of the stomach. Morphological characteristics affecting survival. Arch Surg. 1962 Nov;85:754–763. doi: 10.1001/archsurg.1962.01310050056010. [DOI] [PubMed] [Google Scholar]
  48. MONIS B., WEINBERG T. Cytochemical study of esterase activity of human neoplasms and stromal macrophages. Cancer. 1961 Mar-Apr;14:369–377. doi: 10.1002/1097-0142(196103/04)14:2<369::aid-cncr2820140217>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  49. Maccarty W. C. LONGEVITY IN CANCER: A STUDY OF 293 CASES. Ann Surg. 1922 Jul;76(1):9–12. [PMC free article] [PubMed] [Google Scholar]
  50. Martin R. F., Beckwith J. B. Lymphoid infiltrates in neuroblastomas: their occurrence and prognostic significance. J Pediatr Surg. 1968 Feb;3(1):161–164. doi: 10.1016/0022-3468(68)91005-1. [DOI] [PubMed] [Google Scholar]
  51. Morrison A. S., Black M. M., Lowe C. R., MacMahon B., Yuasa S. Some international differences in histology and survival in breast cancer. Int J Cancer. 1973 Mar 15;11(2):261–267. doi: 10.1002/ijc.2910110203. [DOI] [PubMed] [Google Scholar]
  52. Nairn R. C., Nind A. P., Guli E. P., Davies D. J., Rolland J. M., McGiven A. R., Hughes E. S. Immunological reactivity in patients with carcinoma of colon. Br Med J. 1971 Dec 18;4(5789):706–709. doi: 10.1136/bmj.4.5789.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Newton K. A., Mackenzie D. H., Spittle M. F., Mikolajczuk A. Hodgkin's disease. A clinico-pathological study of 250 cases with a 5-year follow-up. Br J Cancer. 1973 Jan;27(1):80–91. doi: 10.1038/bjc.1973.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Nind A. P., Nairn R. C., Rolland J. M., Guli E. P., Hughes E. S. Lymphocyte anergy in patients with carcinoma. Br J Cancer. 1973 Aug;28(2):108–117. doi: 10.1038/bjc.1973.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Pierce G. B., Jr Ultrastructure of human testicular tumors. Cancer. 1966 Dec;19(12):1963–1983. doi: 10.1002/1097-0142(196612)19:12<1963::aid-cncr2820191224>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  56. Prehn R. T. The immune reaction as a stimulator of tumor growth. Science. 1972 Apr 14;176(4031):170–171. doi: 10.1126/science.176.4031.170. [DOI] [PubMed] [Google Scholar]
  57. Pretlow T. G., 2nd, Luberoff D. E., Hamilton L. J., Weinberger P. C., Maddox W. A., Durant J. R. Pathogenesis of Hodgkin's disease: separation and culture of different kinds of cells from Hodgkin's disease in a sterile isokinetic gradient of Ficoll in tissue culture medium. Cancer. 1973 May;31(5):1120–1126. doi: 10.1002/1097-0142(197305)31:5<1120::aid-cncr2820310513>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  58. Richters A., Sherwin R. P. Mitotic lymphocytes in primary tissue cultures of normal and neoplastic human lung. Lab Invest. 1965 Dec;14(12):2122–2132. [PubMed] [Google Scholar]
  59. Richters A., Sherwin R. P., Richters V. The lymphocyte and human lung cancers. Cancer Res. 1971 Mar;31(3):214–222. [PubMed] [Google Scholar]
  60. Roberts M. M., Bass E. M., Wallace I. W., Stevenson A. Local immunoglobulin production in breast cancer. Br J Cancer. 1973 Apr;27(4):269–275. doi: 10.1038/bjc.1973.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Sarma K. P. The role of lymphoid reaction in bladder cancer. J Urol. 1970 Dec;104(6):843–849. doi: 10.1016/s0022-5347(17)61849-4. [DOI] [PubMed] [Google Scholar]
  62. Saxén E., Penttinen K. Differences in the effect of individual human sera on cell cultures. J Natl Cancer Inst. 1965 Jul;35(1):67–73. doi: 10.1093/jnci/35.1.67. [DOI] [PubMed] [Google Scholar]
  63. Sistrunk W. E., Maccarty W. C. LIFE EXPECTANCY FOLLOWING RADICAL AMPUTATION FOR CARCINOMA OF THE BREAST: A CLINICAL AND PATHOLOGIC STUDY OF 218 CASES. Ann Surg. 1922 Jan;75(1):61–69. [PMC free article] [PubMed] [Google Scholar]
  64. Stewart T. H. The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 2. A correlation between the histologic picture of lymphocyte infiltration of the tumor stroma, the presence of such a reaction, and a discussion of the significance of this phenomenon. Cancer. 1969 Jun;23(6):1380–1387. doi: 10.1002/1097-0142(196906)23:6<1380::aid-cncr2820230620>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  65. Stjernswärd J., Almgård L. E., Franzén S., von Schreeb T., Wadström L. B. Tumour-distinctive cellular immunity to renal carcinoma. Clin Exp Immunol. 1970 Jun;6(6):963–968. [PMC free article] [PubMed] [Google Scholar]
  66. TAKAHASHI K. Squamous cell carcinoma of the esophagus. Stromal inflammatory cell infiltration as a prognostic factor. Cancer. 1961 Sep-Oct;14:921–933. doi: 10.1002/1097-0142(196109/10)14:5<921::aid-cncr2820140504>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  67. Tanaka T., Cooper E. H., Anderson C. K. Lymphocyte infiltration in bladder carcinoma. Rev Eur Etud Clin Biol. 1970 Dec;15(10):1084–1089. [PubMed] [Google Scholar]
  68. Taylor G., Odili J. L. Histological evidence of tumour rejection after active immunotherapy in human malignant disease. Br Med J. 1972 Apr 22;2(5807):183–188. doi: 10.1136/bmj.2.5807.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Tubiana M., Attié E., Flamant R., Gérard-Marchant R., Hayat M. Prognostic factors in 454 cases of Hodgkin's disease. Cancer Res. 1971 Nov;31(11):1801–1810. [PubMed] [Google Scholar]
  70. Underwood J. C., Carr I. The ultrastructure of the lymphoreticular cells in non-lymphoid human neoplasms. Virchows Arch B Cell Pathol. 1972;12(1):39–50. doi: 10.1007/BF02893984. [DOI] [PubMed] [Google Scholar]
  71. Wasserman S. I., Goetzl E. J., Ellman L., Austen K. F. Tumor-associated eosinophilotactic factor. N Engl J Med. 1974 Feb 21;290(8):420–424. doi: 10.1056/NEJM197402212900802. [DOI] [PubMed] [Google Scholar]
  72. White W. C. LATE RESULTS OF OPERATION FOR CARCINOMA OF THE BREAST. Ann Surg. 1927 Nov;86(5):695–701. [PMC free article] [PubMed] [Google Scholar]
  73. Wiener J. Ultrastructural aspects of delayed hypersensitivity. Curr Top Pathol. 1970;52:143–208. doi: 10.1007/978-3-642-95133-6_3. [DOI] [PubMed] [Google Scholar]
  74. YOON I. L. The eosinophil and gastrointestinal carcinoma. Am J Surg. 1959 Feb;97(2):195–200. doi: 10.1016/0002-9610(59)90432-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES